Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

CleanTech Acquisition (CLAQ) Competitors

CleanTech Acquisition logo

CLAQ vs. EKSO, KITT, SYM, NDSN, RRX, ESAB, ATS, HSAI, OUST, and RR

Should you be buying CleanTech Acquisition stock or one of its competitors? The main competitors of CleanTech Acquisition include Ekso Bionics (EKSO), Nauticus Robotics (KITT), Symbotic (SYM), Nordson (NDSN), Regal Rexnord (RRX), ESAB (ESAB), ATS (ATS), Hesai Group (HSAI), Ouster (OUST), and Richtech Robotics (RR).

CleanTech Acquisition vs.

Ekso Bionics (NASDAQ:EKSO) and CleanTech Acquisition (NASDAQ:CLAQ) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment, valuation and community ranking.

Ekso Bionics presently has a consensus price target of $5.00, indicating a potential upside of 1,044.16%. Given Ekso Bionics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Ekso Bionics is more favorable than CleanTech Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ekso Bionics
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
CleanTech Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Ekso Bionics received 324 more outperform votes than CleanTech Acquisition when rated by MarketBeat users. However, 100.00% of users gave CleanTech Acquisition an outperform vote while only 54.44% of users gave Ekso Bionics an outperform vote.

CompanyUnderperformOutperform
Ekso BionicsOutperform Votes
325
54.44%
Underperform Votes
272
45.56%
CleanTech AcquisitionOutperform Votes
1
100.00%
Underperform Votes
No Votes

CleanTech Acquisition has a net margin of 0.00% compared to Ekso Bionics' net margin of -62.95%. CleanTech Acquisition's return on equity of -7.24% beat Ekso Bionics' return on equity.

Company Net Margins Return on Equity Return on Assets
Ekso Bionics-62.95% -83.09% -39.03%
CleanTech Acquisition N/A -7.24%0.33%

6.4% of Ekso Bionics shares are held by institutional investors. Comparatively, 71.7% of CleanTech Acquisition shares are held by institutional investors. 6.1% of Ekso Bionics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Ekso Bionics had 3 more articles in the media than CleanTech Acquisition. MarketBeat recorded 3 mentions for Ekso Bionics and 0 mentions for CleanTech Acquisition. Ekso Bionics' average media sentiment score of 0.96 beat CleanTech Acquisition's score of 0.00 indicating that Ekso Bionics is being referred to more favorably in the media.

Company Overall Sentiment
Ekso Bionics Positive
CleanTech Acquisition Neutral

CleanTech Acquisition has lower revenue, but higher earnings than Ekso Bionics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ekso Bionics$17.93M0.61-$15.20M-$0.57-0.77
CleanTech AcquisitionN/AN/A-$600KN/AN/A

Summary

Ekso Bionics beats CleanTech Acquisition on 8 of the 14 factors compared between the two stocks.

Remove Ads
Get CleanTech Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLAQ and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLAQ vs. The Competition

MetricCleanTech AcquisitionGeneral Industrial Machinery, Industry SectorNASDAQ Exchange
Market Cap$21.56M$3.35B$2.48B$7.83B
Dividend YieldN/A0.98%13.12%4.01%
P/E RatioN/A16.0011.4318.74
Price / SalesN/A8.734,117,054.5790.78
Price / CashN/A171.2366.9034.64
Price / Book-2.785.413.204.23
Net Income-$600,000.00$39.72M-$266.20M$247.47M

CleanTech Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLAQ
CleanTech Acquisition
N/A$1.00
+1.0%
N/A+213.0%$21.56MN/A0.002,021High Trading Volume
EKSO
Ekso Bionics
3.2141 of 5 stars
$0.46
+1.8%
$5.00
+987.0%
-67.9%$11.42M$17.93M-0.7160Short Interest ↓
KITT
Nauticus Robotics
0.3087 of 5 stars
$1.06
-6.2%
N/A-91.3%$6.79M$2.40M-0.024Short Interest ↑
Gap Up
SYM
Symbotic
3.3053 of 5 stars
$22.15
-5.3%
$38.20
+72.5%
-55.2%$13.03B$1.91B-316.381,120Positive News
Gap Up
NDSN
Nordson
4.6043 of 5 stars
$206.55
+0.3%
$256.20
+24.0%
-27.0%$11.76B$2.67B26.287,330Positive News
RRX
Regal Rexnord
4.6014 of 5 stars
$122.82
-1.6%
$195.13
+58.9%
-34.5%$8.14B$6.03B41.6326,000
ESAB
ESAB
2.5705 of 5 stars
$120.35
-2.0%
$134.14
+11.5%
+4.8%$7.28B$2.74B27.869,000News Coverage
Positive News
ATS
ATS
1.235 of 5 stars
$26.87
-1.4%
$30.50
+13.5%
-23.2%$2.63B$2.75B40.717,000
HSAI
Hesai Group
2.1345 of 5 stars
$18.05
-1.8%
$22.80
+26.3%
+200.4%$2.29B$2.08B-41.021,122Short Interest ↑
Gap Down
OUST
Ouster
2.3265 of 5 stars
$10.62
-5.4%
$13.33
+25.5%
+20.2%$528.57M$111.10M-4.13280Short Interest ↓
Gap Down
RR
Richtech Robotics
2.7054 of 5 stars
$2.32
-7.2%
$3.00
+29.3%
+33.8%$259.96M$4.39M-17.8551Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:CLAQ) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners